Annual Short Term Debt
$115.00 K
+$115.00 K+100.00%
December 31, 2023
Summary
- As of February 8, 2025, VYNE annual short term debt is $115.00 thousand, with the most recent change of +$115.00 thousand (+100.00%) on December 31, 2023.
- During the last 3 years, VYNE annual short term debt has fallen by -$642.00 thousand (-84.81%).
- VYNE annual short term debt is now -84.81% below its all-time high of $757.00 thousand, reached on December 31, 2020.
Performance
VYNE Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Short Term Debt
$123.00 K
+$3000.00+2.50%
September 30, 2024
Summary
- As of February 8, 2025, VYNE quarterly short term debt is $123.00 thousand, with the most recent change of +$3000.00 (+2.50%) on September 30, 2024.
- Over the past year, VYNE quarterly short term debt has increased by +$3000.00 (+2.50%).
- VYNE quarterly short term debt is now -99.64% below its all-time high of $33.81 million, reached on June 30, 2021.
Performance
VYNE Quarterly Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Short Term Debt Formula
Short-Term Debt = Current Portion of Long-Term Debt + Short-Term Loans + Commercial Paper + Other Short-Term Borrowings
VYNE Short Term Debt Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +100.0% | +2.5% |
| 3 y3 years | -84.8% | +100.0% |
| 5 y5 years | +100.0% | +100.0% |
VYNE Short Term Debt Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -67.0% | -100.0% | -64.8% | -100.0% |
| 5 y | 5-year | -84.8% | -100.0% | -99.6% | -100.0% |
| alltime | all time | -84.8% | -100.0% | -99.6% | -100.0% |
VYNE Therapeutics Short Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $123.00 K(+2.5%) |
| Jun 2024 | - | $120.00 K(+2.6%) |
| Mar 2024 | - | $117.00 K(+1.7%) |
| Dec 2023 | $115.00 K(>+9900.0%) | $115.00 K(>+9900.0%) |
| Dec 2022 | $0.00(-100.0%) | $0.00(0.0%) |
| Sep 2022 | - | $0.00(-100.0%) |
| Jun 2022 | - | $31.00 K(-73.5%) |
| Mar 2022 | - | $117.00 K(-66.5%) |
| Dec 2021 | $349.00 K | $349.00 K(+26.0%) |
| Sep 2021 | - | $277.00 K(-99.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2021 | - | $33.81 M(+5125.5%) |
| Mar 2021 | - | $647.00 K(-14.5%) |
| Dec 2020 | $757.00 K(+8.1%) | $757.00 K(-31.1%) |
| Sep 2020 | - | $1.10 M(-11.8%) |
| Jun 2020 | - | $1.25 M(+23.4%) |
| Mar 2020 | - | $1.01 M(+44.1%) |
| Dec 2019 | $700.00 K(>+9900.0%) | $700.00 K(-5.5%) |
| Sep 2019 | - | $741.00 K(+3.6%) |
| Jun 2019 | - | $715.00 K(+4.5%) |
| Mar 2019 | - | $684.00 K(>+9900.0%) |
| Dec 2018 | $0.00 | $0.00 |
FAQ
- What is VYNE Therapeutics annual short term debt?
- What is the all time high annual short term debt for VYNE Therapeutics?
- What is VYNE Therapeutics annual short term debt year-on-year change?
- What is VYNE Therapeutics quarterly short term debt?
- What is the all time high quarterly short term debt for VYNE Therapeutics?
- What is VYNE Therapeutics quarterly short term debt year-on-year change?
What is VYNE Therapeutics annual short term debt?
The current annual short term debt of VYNE is $115.00 K
What is the all time high annual short term debt for VYNE Therapeutics?
VYNE Therapeutics all-time high annual short term debt is $757.00 K
What is VYNE Therapeutics annual short term debt year-on-year change?
Over the past year, VYNE annual short term debt has changed by +$115.00 K (+100.00%)
What is VYNE Therapeutics quarterly short term debt?
The current quarterly short term debt of VYNE is $123.00 K
What is the all time high quarterly short term debt for VYNE Therapeutics?
VYNE Therapeutics all-time high quarterly short term debt is $33.81 M
What is VYNE Therapeutics quarterly short term debt year-on-year change?
Over the past year, VYNE quarterly short term debt has changed by +$3000.00 (+2.50%)